FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
9 letters match. Newest first.
-
BiologicsConceive Fertility Center
FDA says Conceive Fertility Center in Dallas used incomplete donor screening and testing for reproductive cells.
High risk -
BiologicsLouisville Reproductive Center
Louisville Reproductive Center failed to properly test and screen semen donors for infectious diseases, FDA found.
High risk -
BiologicsAkan Biosciences, Inc.
FDA warned Akan Biosciences over unapproved Ayama injectable and donor-screening failures.
High risk -
BiologicsWashington Fertility Center
FDA warned Washington Fertility Center about incomplete donor eligibility screening and testing for oocytes, semen, and embryos.
High risk -
DevicesBeckman Coulter Inc.
FDA warns Beckman Coulter over inadequate quality-system procedures for DxI 9000 immunoassay devices.
High risk -
BiologicsMark S. Denker, M.D., PA dba Palm Beach Fertility Center
FDA warns Boca Raton fertility center over failures to screen sperm and egg donors for infectious disease risk.
High risk -
BiologicsZhang Medical P.C. dba New Hope Fertility Center
New Hope Fertility Center failed to properly screen and test oocyte and semen donors for communicable diseases, FDA says.
High risk -
DrugsKleenhanz, LLC
FDA told Kleenhanz its antiseptic towelettes were unapproved drugs because the website and Twitter claimed they fight COVID-19 and other diseases.
High risk -
BiologicsCooper Institute
FDA warned Houston fertility clinic Cooper Institute that it failed to test and screen oocyte donors for infectious diseases.
High risk